SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

Clinical trial NCT06940921 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06940921
Sponsor: Zhang Tao
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer Advanced Colorectal Cancer Advanced Ovarian Cancer Peritoneal Metastasis

Start date: 2025-03-20
Primary completion: 2027-11-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.